|
Mouse Strain information
|
||||||||||||||||||||||||||
| APB ID | 287 | |||||||||||||||||||||||||
| Added | 03/05/2006 | |||||||||||||||||||||||||
| Last Edited | 27/09/2016 | |||||||||||||||||||||||||
| Strain nomenclature: | BALB/c-Il4tm2Nnt/AnuApb | |||||||||||||||||||||||||
| Nickname: | Tune | |||||||||||||||||||||||||
|
Genetics
|
||||||||||||||||||||||||||
| Strain Types |
Mutant strain
|
|||||||||||||||||||||||||
| Genetic Details |
Targeted knockout
|
|||||||||||||||||||||||||
| Mode of Inheritance | Recessive | |||||||||||||||||||||||||
|
||||||||||||||||||||||||||
| Mutant Construction Technique | None | |||||||||||||||||||||||||
|
Phenotype
|
||||||||||||||||||||||||||
| Phenotype Homozygous State | abnormal dendritic cell differentiation: numbers of MHCII/CD86-positive dendritic cells found in inflamed lungs are reduced by two-thirds decreased IgE level: reduced serum concentrations of IgE, however lymphocyte composition and function comparable to wild-type controls decreased IgG1 level: reduced serum concentrations of IgG1, however lymphocyte composition and function comparable to wild-type controls abnormal dendritic cell antigen presentation: memory CD4 T cells activated by mutant DCs from inflamed lungs secrete low levels of Th2 cytokines increased interferon-gamma secretion: T cells from mice sensitized and challenged with OVA produce more IFN-gamma than controls decreased interleukin-13 secretion: lymphocytes from mice sensitized and challenged with OVA produce less IL-13 than controls decreased interleukin-5 secretion: lymphocytes from mice sensitized and challenged with OVA produce less IL-5 than controls decreased susceptibility to autoimmune disorder: mice fail to develop blood eosinophilia after being sensitized and challenged with OVA peptide airway hyperresponsiveness still occurs in these mice though less mucosal cells are found in the inflamed airway hematopoietic system abnormal dendritic cell differentiation: numbers of MHCII/CD86-positive dendritic cells found in inflamed lungs are reduced by two-thirds | |||||||||||||||||||||||||
| Original Genetic Background | BALB/c | |||||||||||||||||||||||||
| Genetic Background Currently Maintained | BALB/c | |||||||||||||||||||||||||
|
Strain identification
|
||||||||||||||||||||||||||
| How is this strain characterised? |
Genotyping
|
|||||||||||||||||||||||||
|
Fertility and Strain maintenance
|
||||||||||||||||||||||||||
|
||||||||||||||||||||||||||
|
Relevant bibliographic / database references
|
||||||||||||||||||||||||||
|
||||||||||||||||||||||||||
|
||||||||||||||||||||||||||
|
General information
|
||||||||||||||||||||||||||
| Associated IP rights? | No | |||||||||||||||||||||||||
| Does it Model a Human Condition? | Unknown | |||||||||||||||||||||||||
| Applicable Research Areas |
Cell biology
Haematology Immunology and inflammation |
|||||||||||||||||||||||||
| Keywords |
|
|||||||||||||||||||||||||
| Is the strain available in any form to other researchers | Yes | |||||||||||||||||||||||||
| APB stock stored as: |
Cryopreserved sperm (from 10 mice)
|
|||||||||||||||||||||||||
| APB stock genotyped verified by: | Unverified | |||||||||||||||||||||||||
| Are live mice available? | No | |||||||||||||||||||||||||
| MTA needs to be signed? | Yes | |||||||||||||||||||||||||
